Akin-Bali, Dilara FatmaSagkan, Rahsan Ilikci2024-11-072024-11-0720210250-46851303-829Xhttps://doi.org/10.1515/tjb-2020-0233https://search.trdizin.gov.tr/tr/yayin/detay/492670https://hdl.handle.net/11480/15379Objectives: Recent advances in defining the genetic landscape of has shown the host cell-SARS-CoV-2 interaction via ACE2 protein and the presence of at least three additional virus invasion genes including TMPRSS2, FURIN, CD147/BSG. In current study, we investigated the mutation and m-RNA expression patterns of target genes by evaluating the associations between genetic and epigenetic mechanisms in the target genes and susceptibility of SARS-CoV-2 infection of renal cancer subtypes. Methods: We investigated the mutation and m-RNA expression patterns of our target genes. The promoter methylation profiles of target genes were tested in the UALCAN database. Results: The total rate of carrying genetic anomaly in the target genes including was 1.6% and seven mutations, one of which had a pathogenic feature, were detected. The expression analysis results in renal cancer groups showed that while the KIRC and KIRP patients had a lower level of TMPRSS2 than the healthy control, their ACE2 level was high. KICH patients had a higher level of CD147/BSG expression than the healthy group. The promoter methylation levels of ACE2 in KIRC and KIRP were reduced. Conclusions: We concluded that renal cancer patients may be more sensitive to SARS-CoV-2 infection, which may worsen the prognosis.eninfo:eu-repo/semantics/openAccessACE2CD147/BSGCOVID-19FURINmethylationrenal cancerSevere acute respiratory syndrome coronavirus 2TMPRSS2Article46214515510.1515/tjb-2020-02332-s2.0-85106214090Q4492670WOS:000646210300004Q4